{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:37:04Z","timestamp":1778661424130,"version":"3.51.4"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1097\/rlu.0b013e31829b1f26","type":"journal-article","created":{"date-parts":[[2013,7,20]],"date-time":"2013-07-20T14:31:13Z","timestamp":1374330673000},"page":"640-642","source":"Crossref","is-referenced-by-count":4,"title":["Increased FDG Uptake of the Bone Marrow Mimicking Malignancy in a Patient of Eosinophilia Secondary to Sparganum mansoni Infection"],"prefix":"10.1097","volume":"39","author":[{"given":"Aisheng","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changjing","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210204","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2141.2006.06038.x","article-title":"Eosinophilia: secondary, clonal and idiopathic.","volume":"133","author":"Tefferi","year":"2006","journal-title":"Br J Haematol"},{"key":"R2-13-20210204","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/MNM.0b013e32832fa254","article-title":"Clinical significance of diffusely increased splenic uptake on FDG-PET.","volume":"30","author":"Liu","year":"2009","journal-title":"Nucl Med Commun"},{"key":"R3-13-20210204","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/01.rlu.0000079394.76990.08","article-title":"Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging.","volume":"28","author":"Chiang","year":"2003","journal-title":"Clin Nucl Med"},{"key":"R4-13-20210204","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/014107689909200410","article-title":"Bone marrow involvement in breast cancer detected by positron emission tomography.","volume":"92","author":"Lewanski","year":"1999","journal-title":"J R Soc Med"},{"key":"R5-13-20210204","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/RLU.0b013e318148b434","article-title":"Rhabdomyosarcoma with widespread bone marrow infiltration: beneficial management role of F-18 FDG PET.","volume":"32","author":"Seshadri","year":"2007","journal-title":"Clin Nucl Med"},{"key":"R6-13-20210204","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/01.rlu.0000178029.47624.66","article-title":"Myelofibrosis on F-18 FDG PET Imaging.","volume":"30","author":"Burrell","year":"2005","journal-title":"Clin Nucl Med"},{"key":"R7-13-20210204","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/01.rlu.0000242685.55001.67","article-title":"Diffuse bone marrow uptake on F-18 FDG PET in patients with myelodysplastic syndromes.","volume":"31","author":"Inoue","year":"2006","journal-title":"Clin Nucl Med"},{"key":"R8-13-20210204","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00003072-200410000-00010","article-title":"Diffuse bone marrow accumulation of FDG in a patient with chronic myeloid leukemia mimics hematopoietic cytokine-mediated FDG uptake on positron emission tomography.","volume":"29","author":"Takalkar","year":"2004","journal-title":"Clin Nucl Med"},{"key":"R9-13-20210204","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1473-3099(09)70113-6","article-title":"Bone marrow involvement in Q feverdetection by fluorine-18-labelled fluorodeoxyglucose PET.","volume":"9","author":"Alwis","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"R10-13-20210204","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1200\/JCO.1998.16.1.173","article-title":"Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy.","volume":"16","author":"Sugawara","year":"1998","journal-title":"J Clin Oncol"},{"key":"R11-13-20210204","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.rlu.0000082670.19100.83","article-title":"Diffusely increased F-18 FDG uptake in bone marrow in a patient with acute anemia and recent erythropoietin therapy.","volume":"28","author":"Plantade","year":"2003","journal-title":"Clin Nucl Med"},{"key":"R12-13-20210204","first-page":"794","article-title":"Quantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines.","volume":"36","author":"Yao","year":"1995","journal-title":"J Nucl Med"},{"key":"R13-13-20210204","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s12149-008-0146-z","article-title":"(18)F-FDG-PETCT findings of granulocyte colony stimulating factor (G-CSF)-producing lung tumors.","volume":"22","author":"Morooka","year":"2008","journal-title":"Ann Nucl Med"},{"key":"R14-13-20210204","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/RLU.0b013e31817deb67","article-title":"F-18 FDG PET imaging in a patient with granulocyte colony stimulating factor producing pulmonary pleomorphic carcinoma.","volume":"33","author":"Takahashi","year":"2008","journal-title":"Clin Nucl Med"},{"key":"R15-13-20210204","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00259-007-0628-6","article-title":"FDG uptake by the bone marrow in NSCLC patients is related to TGF-beta but not to VEGF or G-CSF serum levels.","volume":"35","author":"Van de Wiele","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R16-13-20210204","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/RLU.0b013e3181c7be63","article-title":"Increased bone marrow activity on F-18-FDG PETCT in granulocyte colony stimulating factor producing anaplastic thyroid carcinoma.","volume":"35","author":"Zweifel","year":"2010","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0b013e31829b1f26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:31:13Z","timestamp":1621884673000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201407000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e31829b1f26","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}